Detalles de la búsqueda
1.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111434
2.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666013
3.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol
; 20(1): 159, 2021 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332558
4.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845558
5.
Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2349-2353, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31215715
6.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2474-2485, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31297947
7.
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Cardiovasc Diabetol
; 17(1): 150, 2018 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30486889
8.
Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden.
Allergy
; 78(8): 2311-2314, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919650
9.
Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study.
Pulm Pharmacol Ther
; 38: 10-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27113029
10.
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes.
Prim Care Diabetes
; 17(5): 411-419, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37544790
11.
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
Front Endocrinol (Lausanne)
; 13: 831676, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527995
12.
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
J Diabetes Complications
; 35(12): 108077, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34686406
13.
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
Diabetes Res Clin Pract
; 178: 108947, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252505
14.
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.
Drug Saf
; 44(4): 467-478, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548020
15.
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
ESC Heart Fail
; 8(2): 1711-1716, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570253
16.
Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study.
Diabetes Res Clin Pract
; 165: 108250, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32531326
17.
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study.
Lancet Diabetes Endocrinol
; 8(7): 606-615, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32559476
18.
Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study.
BMJ Open Diabetes Res Care
; 7(1): e000627, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31114700
19.
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study.
Diabetes Res Clin Pract
; 151: 20-32, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30904743
20.
Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015.
Acta Diabetol
; 56(8): 889-897, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963308